Forma Therapeutics Holdings, Inc.
FMTXDelisted Oct 14, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001538927
Forma Therapeutics Holdings, Inc. was delisted on Oct 14, 2022; its insiders filed their last Form 4 on Oct 14, 2022; 139 institutions reported holding it in 13F filings for Q3 2022, worth $835.0M in total; HHLR Advisors (Hillhouse) was the only superinvestor holding it.
Q4 2021 vs. Q3 2021
How the institutions holding Forma Therapeutics Holdings, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 89 | 93 | +4 |
| Shares | 39.4M | 41.4M | +1.93M (+4.9%) |
| Value | $914.2M | $587.9M | −$326.3M (−35.7%) |
New holders (19)
Institutions that held Forma Therapeutics Holdings, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 1,856,000 | $26.4M | 0.64% |
| EDBI Pte Ltd | 1,268,805 | $18.0M | 9.80% |
| Point72 Asset Management, L.P. | 595,900 | $8.47M | 0.04% |
| Parkman Healthcare Partners LLC | 100,000 | $1.42M | 0.32% |
| AlphaCrest Capital Management LLC | 71,383 | $1.01M | 0.04% |
| Citadel Advisors LLC | 70,132 | $998.0K | 0.00% |
| Wellington Management Group LLP | 50,863 | $723.0K | 0.00% |
| Jump Financial, LLC | 38,200 | $543.0K | 0.03% |
| Price T Rowe Associates Inc | 15,995 | $227.0K | 0.00% |
| Squarepoint Ops LLC | 15,728 | $224.0K | 0.00% |
| Gsa Capital Partners LLP | 15,590 | $222.0K | 0.03% |
| Allspring Global Investments Holdings, LLC | 13,294 | $189.0K | 0.00% |
| Qube Research & Technologies Ltd | 12,995 | $185.0K | 0.00% |
| Marshall Wace, LLP | 4,631 | $66.0K | 0.00% |
| Ensign Peak Advisors, Inc | 4,580 | $65.0K | 0.00% |
| Denali Advisors LLC | 4,200 | $60.0K | 0.02% |
| Simplex Trading, LLC | 301 | $4.00K | 0.00% |
| Advisor Group Holdings, Inc. | 14 | $0 | 0.00% |
| Parallel Advisors, LLC | 18 | $0 | 0.00% |
Sold out (15)
Institutions that held Forma Therapeutics Holdings, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Lone Pine Capital LLCSuperinvestorLone Pine Capital | 800,000 | $18.6M |
| Opaleye Management Inc. | 182,950 | $4.24M |
| EcoR1 Capital, LLC | 90,141 | $2.09M |
| Voloridge Investment Management, LLC | 70,779 | $1.64M |
| Neuberger Berman Group LLC | 32,301 | $749.0K |
| Pinz Capital Management, LP | 13,000 | $301.0K |
| Winton Group Ltd | 10,291 | $239.0K |
| Matisse Capital | 10,200 | $237.0K |
| Principal Financial Group Inc | 8,889 | $206.0K |
| DekaBank Deutsche Girozentrale | 5,000 | $111.0K |
| Penserra Capital Management LLC | 1,085 | $25.0K |
| Point72 Hong Kong Ltd | 938 | $22.0K |
| Red Tortoise LLC | 295 | $6.00K |
| Captrust Financial Advisors | 40 | $1.00K |
| Massmutual Trust Co FSB | 21 | $0 |